These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26005016)

  • 21. Differentially expressed serum haptoglobin alpha chain isoforms with potential application for diagnosis of head and neck cancer.
    Chen CB; Su YC; Huang TT; Ho HC; Chang YT; Tung YT; Lee WC
    Clin Chim Acta; 2008 Dec; 398(1-2):48-52. PubMed ID: 18727923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and significance of serum protein markers of small-cell lung cancer.
    Han M; Liu Q; Yu J; Zheng S
    J Clin Lab Anal; 2008; 22(2):131-7. PubMed ID: 18348318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer].
    Kasprzyk M; Dyszkiewicz W; Zwaruń D; Leśniewska K; Wiktorowicz K
    Pneumonol Alergol Pol; 2008; 76(5):321-6. PubMed ID: 19003761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer.
    Hoagland LF; Campa MJ; Gottlin EB; Herndon JE; Patz EF
    Cancer; 2007 Nov; 110(10):2260-8. PubMed ID: 17918261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and identification of Serum Amyloid A protein elevated in lung cancer serum.
    Dai S; Wang X; Liu L; Liu J; Wu S; Huang L; Xiao X; He D
    Sci China C Life Sci; 2007 Jun; 50(3):305-11. PubMed ID: 17609886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry.
    Zeng X; Hood BL; Zhao T; Conrads TP; Sun M; Gopalakrishnan V; Grover H; Day RS; Weissfeld JL; Wilson DO; Siegfried JM; Bigbee WL
    J Thorac Oncol; 2011 Apr; 6(4):725-34. PubMed ID: 21304412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
    Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
    J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyzing the percentage of different PD-1
    Hu X; Gu Y; Li D; Zhao S; Hua S; Jiang Y
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1074-1083. PubMed ID: 31381177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there any potential clinical impact of serum phosphorus and magnesium in patients with lung cancer at first diagnosis? A multi-institutional study.
    Kouloulias V; Tolia M; Tsoukalas N; Papaloucas C; Pistevou-Gombaki K; Zygogianni A; Mystakidou K; Kouvaris J; Papaloucas M; Psyrri A; Kyrgias G; Gennimata V; Leventakos K; Panayiotides I; Liakouli Z; Kelekis N; Papaloucas A
    Asian Pac J Cancer Prev; 2015; 16(1):77-81. PubMed ID: 25640394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
    Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
    J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary study of MALDI-TOF mass spectrometry-based screening of patients with the NSCLC serum-specific peptides].
    An J; Tang C; Wang N; Liu Y; Guo W; Li X; Wang Z; He K; Liu X
    Zhongguo Fei Ai Za Zhi; 2013 May; 16(5):233-9. PubMed ID: 23676979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer.
    Ren Y; Hou J; Xu A; Pan Y
    Int J Clin Exp Pathol; 2015; 8(11):14709-16. PubMed ID: 26823795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monitoring changes of serum protein markers in metastatic colorectal carcinoma model].
    Li ZG; Zhao L; Liu L; Ding YQ
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):48-52. PubMed ID: 17374239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer.
    Zhao W; Yu H; Han Z; Gao N; Xue J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(8):9506-11. PubMed ID: 26464712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.
    Molina R; Augé JM; Bosch X; Escudero JM; Viñolas N; Marrades R; Ramírez J; Carcereny E; Filella X
    Tumour Biol; 2009; 30(3):121-9. PubMed ID: 19506400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.
    Howard BA; Wang MZ; Campa MJ; Corro C; Fitzgerald MC; Patz EF
    Proteomics; 2003 Sep; 3(9):1720-4. PubMed ID: 12973732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum protein profiles of patients with lung cancer of different histological types.
    Yang RH; Tian RF; Ren QL; Chui HY; Guo ST; Zhang XD; Song X
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):70-6. PubMed ID: 26668125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.